VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2015 | $94,545,000 | -55.7% | 930,100 | -22.3% | 6.39% | -61.1% |
| Q3 2015 | $213,503,000 | -10.1% | 1,196,900 | +12.0% | 16.43% | -19.7% |
| Q2 2015 | $237,478,000 | +11.8% | 1,069,000 | 0.0% | 20.47% | +8.3% |
| Q1 2015 | $212,325,000 | +36.6% | 1,069,000 | -1.6% | 18.90% | +26.7% |
| Q4 2014 | $155,489,000 | +14.5% | 1,086,500 | +5.0% | 14.92% | +32.1% |
| Q3 2014 | $135,792,000 | -2.0% | 1,035,000 | -5.8% | 11.29% | +10.2% |
| Q2 2014 | $138,568,000 | -22.0% | 1,098,700 | -18.4% | 10.25% | -25.4% |
| Q1 2014 | $177,575,000 | +12.3% | 1,347,000 | 0.0% | 13.73% | +10.6% |
| Q4 2013 | $158,138,000 | +12.5% | 1,347,000 | 0.0% | 12.41% | +8.4% |
| Q3 2013 | $140,533,000 | +21.2% | 1,347,000 | 0.0% | 11.45% | +28.8% |
| Q2 2013 | $115,950,000 | – | 1,347,000 | – | 8.89% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 5,701,010 | $1,266,479,000 | 36.57% |
| Ruane, Cunniff & Goldfarb | 33,884,050 | $7,527,342,000 | 35.90% |
| LeVasseur Capital Partners LLC | 188,804 | $41,943,000 | 34.97% |
| Pershing Square Capital Management | 19,473,933 | $4,326,134,000 | 29.95% |
| FARLEY CAPITAL L.P. | 141,020 | $31,328,000 | 24.16% |
| Ratan Capital Management LP | 1,038,033 | $230,599,000 | 21.97% |
| Marble Arch Investments | 1,069,000 | $237,478,000 | 20.47% |
| Arrow Capital Management, LLC | 144,461 | $32,092,000 | 18.04% |
| Tesuji Partners | 1,368,040 | $303,910,000 | 17.93% |
| ValueAct Holdings | 14,994,261 | $3,330,975,000 | 17.54% |